Literature DB >> 6424509

Regional blood flow in dogs during halothane anesthesia and controlled hypotension produced by nitroprusside or nitroglycerin.

P S Colley, M Sivarajan.   

Abstract

We used the radioactive microsphere method to measure and compare the effects of sodium nitroprusside (SNP) and nitroglycerin (NTG) on organ blood flow during hypotension induced by each drug. The study was done in 10 dogs anesthetized using 0.7% end-tidal halothane. Each animal received both SNP and NTG to decrease the mean arterial blood pressure (MABP) to 45 mm Hg, but the sequence in which the drugs were administered was alternated. Five of the dogs received SNP first and five received NTG first. Organ blood flow was measured after a stable period of hypotension that was brief by necessity in order to avoid cyanide toxicity due to increasing dose requirements for SNP. Measurements were made before and during hypotension induced with each drug. The mean duration of stable hypotension was shorter (P less than 0.05) with NTG (5 +/- 1 min) (mean +/- SEM) than with SNP (7 +/- 1 min). During NTG-induced hypotension, blood flows to the brain, kidneys, liver, gastrointestinal tract, pancreas, and skeletal muscle were maintained at control levels. During SNP-induced hypotension, blood flows to the myocardium, liver, gastrointestinal tract, pancreas, and skeletal muscle were maintained at control levels. NTG increased myocardial blood flow (P less than 0.05), while SNP decreased blood flow to brain (P less than 0.05) and kidneys (P less than 0.01). Both drugs decreased blood flow to the spleen (P less than 0.001). Our results indicate that during the first few minutes of NTG-induced hypotension, blood flows to all organs except the spleen are well-maintained, while the first few minutes of SNP-induced hypotension are associated with decreases in blood flow to brain and kidneys as well as to the spleen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424509

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Exogenous intravascular nitric oxide enhances ventricular function after hemodilution with plasma expander.

Authors:  Surapong Chatpun; Pedro Cabrales
Journal:  Life Sci       Date:  2011-10-26       Impact factor: 5.037

2.  Effects of posture, hypotension and locally applied vasoconstriction on the middle ear microcirculation in anaesthetized humans.

Authors:  C S Degoute; C Dubreuil; M J Ray; J Guitton; M Manchon; V Banssillon; J L Saumet
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

3.  Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.

Authors:  L J van Woerkens; W J van der Giessen; P D Verdouw
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Effects of hypotension on cutaneous and subcutaneous blood flow in anaesthetized humans.

Authors:  G Leftheriotis; J L Saumet; F Kalfon; J Dubost; V Banssillon; M Freidel
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

5.  The effects of prolonged controlled hypotension induced by prostaglandin E1 on renal tubular function.

Authors:  M Fukusaki; O Shibata; T Fujigaki; T Makita; Y Gotoh
Journal:  J Anesth       Date:  1990-07       Impact factor: 2.078

6.  Effects of sodium nitroprusside (MR7S1) and nitroglycerin on the systemic, renal, cerebral, and coronary circulation of dogs anesthetized with enflurane.

Authors:  M Hamaguchi; T Ishibashi; N Katsumata; A Mitomi; S Imai
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

7.  Effect of blood pressure on medial medulla-induced muscle atonia.

Authors:  Y Y Lai; J M Siegel; W J Wilson
Journal:  Am J Physiol       Date:  1987-06

8.  Heart rate and blood pressure changes during sleep-waking cycles and cataplexy in narcoleptic dogs.

Authors:  J M Siegel; K S Tomaszewski; H Fahringer; G Cave; T Kilduff; W C Dement
Journal:  Am J Physiol       Date:  1989-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.